IPIsabella Worlewenut Paulsen

Isabella Worlewenut Paulsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Isabella Worlewenut Paulsen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Erikstrup

    Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark

    1 shared publication
  • Christoffer Hother

    Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    1 shared publication
  • Dorte Tholstrup

    Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    1 shared publication
  • Elisabeth Ralfkiær

    Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    1 shared publication
  • Erik Sørensen

    Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    1 shared publication
  • Henrik Hjalgrim

    Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

    1 shared publication

Latest Publications

  • Open Access

    The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples

    by Steffen Jørgensen, Isabella Worlewenut Paulsen, Jakob Werner Hansen, Dorte Tholstrup, Christoffer Hother, Erik Sørensen, Mikkel Steen Petersen, Kaspar Rene Nielsen, Klaus Rostgaard, Margit Anita Hørup Larsen, et al.

    MicroRNAs are small regulatory RNAs that are deregulated in a wide variety of human cancers, including different types of B-cell lymphoma. Nevertheless, the feasibility of circulating microRNA for early diagnosis of B-cell lymphoma has not been established. To address the possibility of detecting specific circulating microRNAs years before a B-cell lymphoma is diagnosed, we studied the plasma expression of microRNA first in pre-treatment samples from patients with diffuse large B-cell lymphoma and subsequently in repository samples from blood donors who later developed B-cell lymphomas. In addition, we studied the microRNA expression in the diagnostic lymphoma biopsy. The most strongly induced (miR-326) and suppressed (miR-375) plasma microRNA at diagnosis, when compared with healthy blood donors, were also substantially up- or down-regulated in plasma repository samples taken from several months to up to two years before the blood donors were diagnosed with B-cell lymphoma. Importantly, at these time points the donors had no signs of disease and felt healthy enough to donate blood. In conclusion, this first study of plasma microRNA profiles from apparently healthy individuals, taken several years before B-cell lymphoma diagnosis, suggests that plasma microRNA profiles may be predictive of lymphoma development.